Major Clinical Impact of Platinum-Based Chemotherapy in a Patient with a Borderline Ovarian Cancer

A patient with extensive and painful chest wall involvement from a metastatic borderline cancer of the ovary was treated with a carboplatin plus paclitaxel chemotherapy regimen. She achieved a rather dramatic improvement of pain control, a significant biochemical response with 75% reduction of the C...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jian, Markman, Maurie
Formato: Texto
Lenguaje:English
Publicado: S. Karger AG 2009
Materias:
Published: September 2009
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2914377/
https://www.ncbi.nlm.nih.gov/pubmed/20737032
http://dx.doi.org/10.1159/000237870
_version_ 1782184757641084928
author Chen, Jian
Markman, Maurie
author_facet Chen, Jian
Markman, Maurie
author_sort Chen, Jian
collection PubMed
description A patient with extensive and painful chest wall involvement from a metastatic borderline cancer of the ovary was treated with a carboplatin plus paclitaxel chemotherapy regimen. She achieved a rather dramatic improvement of pain control, a significant biochemical response with 75% reduction of the CA-125 antigen level, but only limited radiographic tumor regression. This experience emphasizes the potential clinical utility of platinum-based cytotoxic chemotherapy in the setting of symptomatic advanced borderline ovarian cancer.
format Text
id pubmed-2914377
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-29143772010-08-24 Major Clinical Impact of Platinum-Based Chemotherapy in a Patient with a Borderline Ovarian Cancer Chen, Jian Markman, Maurie Case Rep Oncol Published: September 2009 A patient with extensive and painful chest wall involvement from a metastatic borderline cancer of the ovary was treated with a carboplatin plus paclitaxel chemotherapy regimen. She achieved a rather dramatic improvement of pain control, a significant biochemical response with 75% reduction of the CA-125 antigen level, but only limited radiographic tumor regression. This experience emphasizes the potential clinical utility of platinum-based cytotoxic chemotherapy in the setting of symptomatic advanced borderline ovarian cancer. S. Karger AG 2009-09-22 /pmc/articles/PMC2914377/ /pubmed/20737032 http://dx.doi.org/10.1159/000237870 Text en Copyright © 2009 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-No-Derivative-Works License (http://creativecommons.org/licenses/by-nc-nd/3.0/). Users may download, print and share this work on the Internet for noncommercial purposes only, provided the original work is properly cited, and a link to the original work on http://www.karger.com and the terms of this license are included in any shared versions.
spellingShingle Published: September 2009
Chen, Jian
Markman, Maurie
Major Clinical Impact of Platinum-Based Chemotherapy in a Patient with a Borderline Ovarian Cancer
title Major Clinical Impact of Platinum-Based Chemotherapy in a Patient with a Borderline Ovarian Cancer
title_full Major Clinical Impact of Platinum-Based Chemotherapy in a Patient with a Borderline Ovarian Cancer
title_fullStr Major Clinical Impact of Platinum-Based Chemotherapy in a Patient with a Borderline Ovarian Cancer
title_full_unstemmed Major Clinical Impact of Platinum-Based Chemotherapy in a Patient with a Borderline Ovarian Cancer
title_short Major Clinical Impact of Platinum-Based Chemotherapy in a Patient with a Borderline Ovarian Cancer
title_sort major clinical impact of platinum-based chemotherapy in a patient with a borderline ovarian cancer
topic Published: September 2009
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2914377/
https://www.ncbi.nlm.nih.gov/pubmed/20737032
http://dx.doi.org/10.1159/000237870
work_keys_str_mv AT chenjian majorclinicalimpactofplatinumbasedchemotherapyinapatientwithaborderlineovariancancer
AT markmanmaurie majorclinicalimpactofplatinumbasedchemotherapyinapatientwithaborderlineovariancancer

Ejemplares similares